Australian Market Report for Hyaluronic Acid Viscosupplementation 2016 – MedCore

Australian Market Report for Hyaluronic Acid Viscosupplementation 2016 – MedCore

0

Hyaluronic acids (HAs) are naturally occurring biopolymer fluids found in the joints that help cushion them from wear. Sufferers of osteoarthritis are deficient in these fluids. One of the treatment options for these patients is HA viscosupplement injections.

  • Year: 2016
  • Scope: 2012-2022
  • Region: Australia
  • Published Date: 03/01/2016
  • Pages: 35
  • Type: MedCore

Viscosupplements are injectable products that come in three varieties of injection regimens. The exact mechanism of their action is unclear, but the therapy works by increasing the viscoelasticity of the synovial fluid, thereby reducing friction between the joints. The immediate short-term benefit appears to be mainly pain relief, more so than actual healing, although this does allow for long-term improvements in mobility and range of motion. The products are appropriate in cases where the patient has failed to respond to pharmacological or steroid therapy and there is no contraindication to injection therapy. The effectiveness of these products has mainly been established for the knee joints, and has not yet been very well established for use in other joints of the body.
Viscoelasticity is a property describing the ability to absorb shock. Fluids that have a high degree of this property provide greater resistance to sudden shocks and impacts than they do to loads that are applied gradually. In an osteoarthritic knee, the cartilage wears faster than it can repair itself. The shock-absorbing quality of hyaluronic acid products reduces this wear on the articular cartilage, allowing it to heal. The product itself does not remain in the joint space long after injection, as it lasts only hours or days. The therapeutic benefit, however, can last up to half a year, indicating that there may be some element of
anti-inflammatory action or stimulation of the body’s natural ability to replenish the joint fluid. Because there is no pharmacologic action associated with the treatment, these products are classified as medical devices in the majority of circumstances. In India, however, most HA products are classified as drugs.



The "Australian Market Report Suite for Orthopedic Biomaterials 2016 - MedSuite" includes analysis on the following companies currently active in this market:
Austofix
Austspine
Baxter
Bioventus
Bone Banks
Cerapedics
DePuy Synthes
Emergo Asia Pacific
Genzyme (Sanofi)
Global Orthopaedic
LMT Surgical
Medtronic
Nuvasive
Prism Surgical Designs
Scient'x Australia
Signature Orthopaedics
Smith & Nephew
Stryker
Surgiplas Medical
Wright Medical
Zimmer Biomet

*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Not Exactly What You Need?
close-link
close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link